United States: 2016 Expected To Be Monumental Year For 340B Drug Discount Program

The 340B Program continues to be an area of focus from federal policymakers, and recent activity and publications indicate that 2016 could be a monumental year for the program. Below is a breakdown of the recent and upcoming key initiatives related to the 340B Program.

2016 Regulatory Agenda: 340B Program Rules

The recently released U.S. Department of Health and Human Services (HHS) regulatory agenda for 2016 includes several planned publications that will affect 340B Program covered entities and drug manufacturers:

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter